House Oversight Committee Launches PBM Investigation
The House Oversight Committee chair launched an investigation on Wednesday into dubious practices used by pharmacy benefit managers, including rebate tactics and market consolidation, and their potential effects on federal health...To view the full article, register now.
Already a subscriber? Click here to view full article